JPRN-jRCT2080221362未知2 期
A phase 2 study of M110101 in seborrheic dermatitis patients
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients diagnosed with seborrheic dermatitis
排除标准
- 未提供
研究者
相似试验
未知
2 期
A phase 2b study of M110101 in seborrheic dermatitis patientsseborrheic dermatitisJPRN-jRCT2080221910Maruho Co.,Ltd.
已完成
4 期
A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic DermatitisSeborrheic DermatitisNCT03567980University of Alabama at Birmingham30
未知
2 期
A phase 2b study of M108101 in acne vulgaris patientsAcne vulgarisJPRN-jRCT2080221392Maruho Co.,Ltd.
已完成
2 期
Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the ScalpSeborrhoeic Dermatitis of the ScalpNCT01137630Moberg Pharma AB98
已完成
3 期
K301 for the Treatment of Seborrhoeic Eczema (SE) of the ScalpSeborrhoeic Eczema of the ScalpNCT01137331Moberg Pharma AB201